VSV-G Antibodies

Santa Cruz Biotechnology offers a broad range of VSV-G monoclonal antibodies for research applications. VSV-G monoclonal antibodies are compatible with multiple techniques, including western blotting (WB), immunoprecipitation (IP), immunofluorescence (IF), immunohistochemistry with paraffin-embedded sections (IHCP), flow cytometry (FCM), and enzyme-linked immunosorbent assay (ELISA). VSV-G, or Vesicular Stomatitis Virus Glycoprotein, plays a crucial role in viral entry and fusion, making it a significant target in virology and cell biology studies. The ability of VSV-G to facilitate the delivery of genetic material into cells has established its importance in developing viral vectors for gene therapy and vaccine research. Understanding VSV-G function continues to drive advancements in therapeutic strategies while expanding knowledge of viral mechanisms. VSV-G research has contributed significantly to breakthroughs in viral vector development and cellular entry mechanisms. Ongoing studies of VSV-G continue to reveal new insights into viral fusion processes and potential therapeutic applications. The high specificity and reliability of Santa Cruz Biotechnology monoclonal antibodies enable researchers worldwide to advance scientific understanding of viral mechanisms and therapeutic development.